The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
about
Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?The concept and evolution of involved site radiation therapy for lymphoma.Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy.Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin's lymphoma. A case study.A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.Incidental Dose to Pelvic Nodal Regions in Prostate-Only RadiotherapyInterobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold.Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists.Bone marrow uptake of 18F-fluorodeoxyglucose in Hodgkin lymphoma without bone involvement: comparison between patients with and without B symptoms.
P2860
Q34610653-15413C50-A653-4A47-84DC-49D8F7B93547Q36898355-2FE5BD58-E227-44BE-AECE-6812C70976CCQ38195016-20CBE9E7-B458-4890-AE9A-252904DBDD81Q38248237-D9665F9F-CCEA-4CEC-BB51-DA4D174A9DC6Q38543470-DD91C846-039A-4812-8DDD-5D3737AA7086Q38658450-436F5212-C002-49A4-9F1A-33F42290F65DQ39539001-80DB9BC4-D501-4F61-AF3F-FAF41E76A66CQ41497405-95117A27-DD57-4C19-A535-5B62C870F2F3Q41901038-6BF04BE2-DE0D-4808-A761-2349417E4CBBQ47884628-A91501FF-2F46-478A-A4AD-C094CD6FFE15Q51127733-92EC2A8F-A154-44CE-BCE5-98BE470249BAQ53084551-62E19DE9-F862-4F81-ACBB-F5C061620148Q53112256-8E3C7042-4CEE-4697-B8AF-2D1D15BA8F19Q55031955-9422B6CD-E469-4740-8B82-C5900B12CC2A
P2860
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The conundrum of Hodgkin lymph ...... ELA lymphoma group guidelines.
@en
The conundrum of Hodgkin lymph ...... ELA lymphoma group guidelines.
@nl
type
label
The conundrum of Hodgkin lymph ...... ELA lymphoma group guidelines.
@en
The conundrum of Hodgkin lymph ...... ELA lymphoma group guidelines.
@nl
prefLabel
The conundrum of Hodgkin lymph ...... ELA lymphoma group guidelines.
@en
The conundrum of Hodgkin lymph ...... ELA lymphoma group guidelines.
@nl
P2093
P1476
The conundrum of Hodgkin lymph ...... GELA lymphoma group guidelines
@en
P2093
Amaury Paumier
Berthe Aleman
EORTC-GELA Lymphoma Group
Evert Noordijk
Guillaume Bonniaud
Mithra Ghalibafian
Paul Meijnders
Philip Poortmans
Richard Van Der Maazen
Theodore Girinsky
P304
P356
10.1016/J.RADONC.2008.05.012
P577
2008-06-12T00:00:00Z